Cancer cells and tumor-associated immune microenvironment (TME)

The cancer cells and tumor-associated immune microenvironment (TME) represent a complex, dynamic ecosystem consisting of malignant cells, immune cells, stromal fibroblasts, endothelial cells, and the extracellular matrix. This environment plays a critical role in tumor progression, as cancer cells actively remodel their surroundings to promote survival, suppress immune surveillance, and facilitate metastasis (National Cancer Institute, 2023). The TME is characterized by chronic inflammation, hypoxia, and a high concentration of immunosuppressive factors that prevent effective T-cell mediated killing of cancer cells (Binnewies et al., Nature Medicine, 2018). Therapeutic strategies targeting this system often focus on reversing immunosuppression, such as through the use of immune checkpoint inhibitors, or disrupting the supportive vascular and stromal networks (Anderson and Simon, Science, 2020). Because this entry describes a multi-component biological system rather than a single protein, enzyme, or receptor, it is classified as a broad therapeutic context rather than a discrete molecular target. Understanding the spatial and functional heterogeneity within the TME is essential for developing effective personalized immunotherapies and overcoming drug resistance (Cell, 2021).

Other names

Tumor microenvironmentTumor immune microenvironmentTIMECancer-immune ecosystemTumor niche

Modulation of the immune response through checkpoint inhibition, inhibition of pro-tumorigenic angiogenesis, and alteration of the metabolic and physical properties of the tumor niche to restore anti-tumor immunity.